Cefoxitin resistance - Clinical Significance in ICU

• Research type

  Research Study

• Full title

  Cefoxitin resistance as a marker of AmpC beta-lactamase production: Clinical significance in the Intensive Care Unit

• IRAS ID

  160150

• Contact name

  Sara Blakeley

• Contact email

  Sara.Blakeley@porthosp.nhs.uk

• Sponsor organisation

  Portsmouth NHS Trust

• Duration of Study in the UK

  0 years, 5 months, 1 days

• Research summary

  Resistance to antibiotics is an enormous problem and is likely to threaten our patients even more in the future. Our study uses retrospective data to look for clinical significance in patients of the presence of a specific type of resistance. It would change and improve antibiotic prescription and patient outcome if its presence is shown to be clinically significant.

• REC name

  North West - Preston Research Ethics Committee

• REC reference

  14/NW/1377

• Date of REC Opinion

  15 Oct 2014

• REC opinion

  Favourable Opinion